Sale!

Psychedelic-Assisted Therapy: Breakthrough Treatments for Complex Mental Health Disorders

Presented by Peter H. Addy, Ph.D.

On Demand | Available Now

$224.50

12 Hours  |   Pre-approved for CEU’s

Description

This online course is on-demand.

Recorded footage and all course content (certificate, videos, quiz) will be available until May 23, 2023. Extensions cannot be granted under any circumstances. 

Registration will close on May 19, 2023. 


Day One

This introductory workshop presents up-to-date findings on how academic and corporate researchers are investigating these same substances as breakthrough medicines to heal trauma, depression, substance use, and other debilitating conditions. At the same time, your clients and members of the general public may be using psychedelics in order to treat their own complex mental health disorders. Learn about current and historical use of “ecstasy”, LSD, psilocybin mushrooms, ketamine, and other psychedelic substances The limitations and risks of psychedelic-assisted therapy will be addressed.  Participants will learn five steps for incorporating psychedelic-informed practices into their treatment. Become a psychedelic-informed clinician so that your clients can talk about their experiences and intentions without fear of judgment or pathologizing. Help them identify risks as well as how their psychedelic use may align with your treatment outcomes.

 

Day Two

Your clients are using psilocybin mushrooms, “ecstasy”, ayahuasca, and other psychedelic substances at increasing rates. Academic and corporate researchers are investigating these same substances as breath through medicines to heal trauma, depression, substance use, and other debilitating conditions. Learn the truth about these controversial medicines and their history. Become a psychedelic-informed clinician so that your clients can talk about their experiences and intentions without fear of judgement or pathologizing. Help them identify risks as well as how their psychedelic use may align with your treatment outcomes.

Day One

  1. What even are psychedelics? The five categories of psychedelic and psychedelic-adjacent medicines
    1. Classic psychedelics
    2. Empathogens
    3. Dissociatives
    4. Complex psychedelics
    5. Atypical psychedelics
  2. Recent clinical research (~2005 – Present?)
    1. Psilocybin
      • Anxiety, depression, obsessive-compulsive disorder, palliative care, substance use
    2. MDMA
      • Post traumatic stress disorder, social anxiety
    3. Ketamine
      • Depression, substance use
    4. Ayahuasca
      • Depression, substance use
    5. LSD
      • Palliative care
    6. Ibogaine
      • Substance use
    7. Micro dosing
  3. Mechanisms of action: Why is this therapeutic?
    1. Accessing the inner healer
    2. Transpersonal change
    3. Default Mode Network
    4. Neuroplasticity
  4. Exclusion criteria and contraindications
    1. Mental health exclusions
    2. Physical health exclusions

 

Day Two

  1. Asking questions: Who uses psychedelics; what, when, where, why, and how they use psychedelics
    1. Epidemiological data
    2. Survey and qualitative data
  2. Breaking the law: Current legal status and history of laws and persecutions
    1. Legal statuses in Canada as of 2021
  3. Your client is using psychedelics: risks, contraindications, diagnoses to consider
    1. Risks to self, other, and treatment
      • Unknown potency and purity
      • Overdose and addiction
    2. Risks to you the therapist
      • Encouraging illegal activities
    3. Psychological and Medical contraindications
      • Interactions with prescription medications
      • Spiritual bypassing
      • Psychosis
    4. DSM-5 diagnostic criteria
  4. Your client is using psychedelics: clarifying intentions, set and setting; how to support
    1. “Set and setting”
    2. Supporting and integrating
    3. Resources
  5. How to make sense of psychedelic experiences: Transpersonal Psychology
    1. Transpersonal content, context, and process
    2. Ascending, descending, and extending transcendence
    3. Practicing with your ancestors

Day One

  1. Describe recent phase 2 and phase 3 clinical trials with psychedelic-assisted psychotherapy in order to compare these to more established treatments
  2. Explain the how treatment in a research study differs from underground or street use of psychedelics in order to manage expectations among clients

Day Two

  1. Understand who is likely to use psychedelics and why in order to better identify client use and understand their use in context
  2. Differentiate between different categories of psychedelics to better assess risks and improve treatment outcomes
  3. Evaluate the current legal landscape in order to help clients have true informed consent for their use and to provide information on legal options, when available
  4. Assess clients for potential harm and understand diagnoses and differential diagnoses that may impact treatment
  5. Practice psychedelic-informed treatment in order to support your clients in their goals

Clinical Professionals: All mental health professionals including, but not limited to Clinical Counsellors, Psychologists, Psychotherapists, Social Workers, Nurses, Occupational Therapists, Hospice and Palliative Care Workers, School Counsellors, Youth Workers, Mental Health Workers, Addiction Specialists, Marital & Family Therapists, Speech Language Pathologists, Vocational Rehabilitation Consultants and all professionals looking to enhance their therapeutic skills.

Peter H. Addy, Ph.D. earned his PhD in clinical psychology studying transcendence, wholeness, and transformation at the Institute of Transpersonal Psychology. As faculty at Yale University, he conducted research with atypical psychedelics including salvinorin A, THC, and ketamine. He has written and spoken about psychedelic science for over a decade, co-founded the Yale Psychedelic Science Group, and documented traditional healing and religious practices that incorporate psychedelic medicine in Mexico. He currently maintains a private practice in Portland, Oregon where he offers therapy, clinical supervision, and professional trainings.

RegistrationEarly bird FeeRegular Fee
Individual Enrollment$449.00N/A
Full-Time Student$359.00N/A

All fees are in Canadian dollars ($CAD).

For group and/or student rates please view our Terms & Conditions and contact webinars@jackhirose.com for more information and registration. 

  • Canadian Psychological Association
    The Alberta College of Social Workers (ACSW) and the Newfoundland and Labrador Association of Social Workers (NLASW) accept CPA-approved continuing education credits